Nonmydriatic Handheld Fundus Cameras Market is segmented By Type (Non-mydriatic Fundus Cameras, Mydriatic Fundus Cameras and Hybrid Fundus Cameras) By Application (Hospitals, Ophthalmology Clinics and Ophthalmic & Optometrist Offices) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2024-2031
Nonmydriatic Handheld Fundus Cameras Market is predicted to reach at a high CAGR 10.1% during the forecast period (2024-2031). The Smartscope is a handheld, non-mydriatic (45°) digital fundus camera that provides general, ophthalmoscopic, otoscopic, and dermatoscopic imaging with a five-megapixel image sensor. Non-mydriatic fundus photography is an effective alternative to direct ophthalmoscopy for examining the ocular fundus in non-ophthalmology settings.
Nonmydriatic Handheld Fundus Cameras Market
| Metrics | Details |
| Market CAGR | 10.1% |
| Segments Covered | By Type, By Application, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
Nonmydriatic Handheld Fundus Cameras Market Dynamics
Increasing incidence of diabetic retinopathy and higher prevalence of age-related macular degeneration (AMD) is expected to drive the Nonmydriatic Handheld Fundus Cameras Market
Increasing incidence of diabetic retinopathy is expected to dominate the market
Diabetic retinopathy is a complication of diabetes that affects the eyes. It's caused by damage to the blood vessels of the light-sensitive tissue at the back of the eye (retina). At first, diabetic retinopathy might cause no symptoms or only mild vision problems. The ideal DR screening strategy remains unclear, but with advancements in ophthalmic photography and communication technologies, there has been growing interest in Telemedicine. While an in-person clinical exam by an eye care provider is the gold standard for diagnosing DR, the standard for photographic detection and classification of DR is mydriatic (dilated) 7-standard field stereoscopic 35-mm color 30-degree retinal photographs that arose from the Early Treatment Diabetic Retinopathy Study (ETDRS). The ETDRS used retinal tabletop camera systems, but these machines are large and not easily portable. With large populations needing to be screened, both ease of use and camera portability are important considerations.
Nearly 9.0% of adults aged 45 and over with diagnosed diabetes had diabetic retinopathy (8.6%), and 4.1% had vision loss due to diabetic retinopathy.
A higher prevalence of age-related macular degeneration (AMD) is expected to drive the nonmydriatic handheld fundus cameras market
Age-related macular degeneration (AMD) is a problem related with the retina. This happens when a part of the retina called the macula is damaged. AMD is a very common problem. It is one of the leading cause of vision loss in people of 50 years or older. In the U.S around 11 million people have some form of age-related macular degeneration and this number is expected to double in 2050 to nearly 22 million. The number of people with macular degeneration is expected to reach 196 million worldwide by 2020 and increase to 288 million by 2040. Nonmydriatic handheld fundus camera can be used for the diagnosis of mascular degeneration.
The high cost of nonmydriatic handheld fundus cameras is expected to hamper the market
Most of the models have incorporated add-on features that contribute to the additional size and weight of the camera. Patients have to be seated upright for photographs to be taken. It is essentially an office-based procedure, hence warranting a visit to the clinic. The overall cost of most table-top models is high, and application in primary healthcare may be limited due to financial constraints. These factors limit their use to high-end specialty healthcare units.
Nonmydriatic Handheld Fundus Cameras Market COVID-19 Impact Analysis
During the COVID 19 pandemic, hospitals and medical practices have been affected due to several changes in their protocols. The ophthalmology procedures have also been affected in this pandemic. The nonmydriatic handheld fundus camera market has been affected during COVID-19 due to decreased hospital admission of patients with diabetic retinopathy and other vision problems.
Nonmydriatic Handheld Fundus Cameras Market Segment Analysis
Nonmydriatic Handheld Fundus Cameras segment is expected to dominate the market
Modern-day fundus cameras are very simple-to-use, revolutionary devices that capture detailed images which are necessary for maintaining eye health and addressing eye diseases at earlier stages. A non-mydriatic fundus camera uses the retina's reflective properties to show details and store images superior to slit lamps and other commonly-used tools. In the majority of cases it does not require pupil dilation and is painless for patients, provides early detection and monitoring of several serious eye health conditions such as macular degeneration, glaucoma, high blood pressure, damage caused by multiple sclerosis, and diabetic retinopathy. In addition, it is easy to operate with little training required, Offers a wide-angle of the targeted retina, and has different filters to choose from for image enhancement.
The hospital segment is expected to dominate the market
Hospitals with their large scale, strong financial capabilities, and broad range of services is expected to see an increase in this segment. Today's nonmydriatic cameras makes fundus photography which is far more patient-friendly. It eliminates the need for dilating drops and bright lights. In turn, eliminating the 30-minute wait for the pupil to dilate and the time for the eye to adjust following a flash of light speeds the exam. This further benefits the patient and saves time for the practitioner and office staff, an important feature in the managed care environment. This feature also is helpful with glaucoma patients for whom dilation is contraindicated. In addition, hospitals provide the best healthcare facilities and advanced treatment options. Hence, this segment is expected to dominate the market.
Geographical Analysis
North America is expected to dominate the nonmydriatic handheld fundus cameras market
Increasing vision-related problems, growing awareness about their treatments, and technological advancements in this region. Governments initiatives for quality, affordable, and speedy healthcare delivery is expected to drive the market.
According to CDC, in the U.S, among adults aged 45 and over who are diagnosed with diabetes, 32.2% had cataracts, 8.6% had diabetic retinopathy, 7.1% had glaucoma, and 4.3% had macular degeneration. In the United States the prevalence of diabetic retinopathy is high. An estimated 4.1 million persons age 40 and older in the US general population have diabetic retinopathy, 1 in 29 persons. An estimated 899 000 persons in this age range have vision-threatening diabetic retinopathy.
Competitive Landscape
Some of the major players in the nonmydriatic handheld fundus cameras market are Grafton Optical Company Ltd, Topcon Medical Systems, Inc., Carl Zeiss Meditec, Inc., Canon, Inc., NIDEK Co., Ltd., CenterVue SpA, Optovue, Inc., Optomed Oy (Ltd.) Tianjin JingMing New Tech. Devp. Co., Ltd, HANSON MEDITEC CO., LTD and Huaian Meide Medical Instrument Co., Ltd
Key Companies to Watch
Grafton Optical Company Ltd
Overview: Grafton Optical is one of the best UK's leading suppliers of ophthalmic instruments, equipping, servicing independent and larger chain opticians as well as Britain's hospitals. Its reputation is based on the ability to source and supply the finest ophthalmic non-mydriatic Fundus Cameras at best possible value for customers. As an independent company, they choose the best instruments worldwide, including the USA, Europe, Japan, and China, without pressure or compromise.
They have also built robust and long-lasting relationships with suppliers, which have enabled them to provide customers with the first-class support they deserve.
Product Portfolio: They are one of the best leading suppliers of ophthalmic instruments, equipping, servicing independent and larger chain opticians as well as Britain's universities and hospitals.
Key Development: Grafton Optical has launched the NFC-700 which is a non-mydriatic fundus camera that provides fully automatic 3D tracking and captures images . This device is an all-in-one fundus camera with automated focus and a manual override option. It does not require a separate PC and has a small desktop footprint. Grafton Optical explained that with its non-mydriatic function, patient comfort is maximized during the diagnosis process.
The nonmydriatic handheld fundus cameras market report would provide access to an approx. 52 market data tables, 41 figures and 180 pages.
